/content/dam/www/people-profile-photos/l/haolong-li/haolong-li-d.jpg
Li
Haolong Li, PhD

Haolong Li, PhD

  • Assistant Professor, Human Biology Division, Fred Hutch
  • Member, Immunotherapy Integrated Research Center (IIRC), Fred Hutch
  • Member, Translational Data Science Integrated Research Center (TDS IRC), Fred Hutch

Background

Dr. Haolong Li investigates the molecular networks that fuel tumor growth in advanced prostate cancer. His work focuses on the genes that regulate androgen receptors, which are critical in prostate cancer progression. Dr. Li studies how aggressive prostate cancers reactivate signaling pathways to escape drugs designed to inhibit androgen receptor binding, leading to drug resistance. He employs innovative genetic screening and sequencing techniques to identify the molecular drivers of drug resistance and discover new therapeutic targets.

Education

PhD, University of British Columbia, 2017

MSc, Jilin University, 2010

BSc, Jilin University, 2009

Find a Clinical Trial

Stories

All news
Glow-tagging the androgen receptor reveals an unexpected vulnerability in advanced prostate cancer A recent study by a Fred Hutch prostate cancer expert finds potential new drug targets using an innovative tagging method that can be applied to other hormone-driven cancers February 19, 2026